According to a new market report published by Lucintel, the future of the allergy diagnostic market looks promising with opportunities in the diagnostics laboratories, hospital-based laboratories, academic and research institutes. The allergy diagnostics market is expected to grow with a CAGR of 11% from 2019 to 2024. The major drivers for this market are rising environmental pollution levels, growing incidences of allergic reactions, increasing healthcare expenditure, and increasing access for allergy diagnosis medical insurance.
To download report brochure, please go to https://www.lucintel.com/allergy-diagnostic-market.aspx and click "report brochure" tab from the menu.
In this market, assay kits, instruments, and services are the major product type. Assay kits is the largest product segment of the allergy diagnostic market.
Within the allergy diagnostics market, in vivo tests and in vitro tests are the major test types. In vivo tests are the largest segment of the allergy diagnostic market.
North America will remain the largest region over the forecast period due to high awareness about allergy diagnostic test among individuals, better regulatory guidelines which mandate allergic testing in all cases of intensive and emergency care, and better healthcare infrastructure to deal with patient’s allergic situations.
Thermo Fisher Scientific, Siemens, Danaher, Omega Diagnostics Group, Hitachi Chemical, Biomérieux, Stallergenes Greer, Hob Biotech Group Suzhou, Hycor Biomedical, Lincoln Diagnostics, and R-Biopharm are among the major manufacturers of allergy diagnostics.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the allergy diagnostics market by product and service, test type, allergen, end user, and region. Lucintel has prepared a comprehensive research report titled "Allergy Diagnostics Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the allergy diagnostics market by product and service, test type, allergen, end user, and region as follows:
By Product and Service [$M shipment analysis for 2013 – 2024]:
Assay Kits
Instruments
Services
By Test Type [$M shipment analysis for 2013 – 2024]:
In Vivo Tests
In Vitro Tests
By Allergen [$M shipment analysis for 2013 – 2024]:
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
By End User [$M shipment analysis for 2013 – 2024]:
Diagnostics Laboratories
Hospital-based Laboratories
Academic and Research Institutes
Other End Users
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Asia-Pacific
ROW
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/allergy-diagnostic-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.